can glp 1 still be compounded Patients struggle as GLP-1 access rapidly shrinks Compounded GLP-1 Treatment

Studies have shown that GLP-1R agonists not only promote insulin secretion and exert glucose-lowering effects but also effectively delay gastric emptying, reduce intestinal motility, activate neural pathways in the hypothalamus and appetite regulation areas, resulting in decreased appetite and reduced food intake, thus treating obesity

A second oral agent or GLP-1 RA

Newer compounds like retatrutide , which acts on three receptors instead of tirzepatide two, are already being compared head-to-head in the retatrutide vs tirzepatide dosage chart

Add a digestive enzyme supplement before your two largest meals

The tirzepatide regulatory landscape has shifted dramatically since the FDA resolved the tirzepatide injection drug shortage and enforcement discretion periods for compounding pharmacies ended - making this context particularly relevant for anyone researching tirzepatide access in 2026

10.1073/pnas.1401861111 Proc